UNICEF SUPPLY DIVISION MEDICAL TECHNICAL TEAM HIV/AIDS: Where Are The Diagnostics ? Ludo Scheerlinck MSc, MBA, MPH.

Slides:



Advertisements
Similar presentations
PROCURING AND DISTRIBUTING ARVs AND OTHER A.R.T COMMODITIES IN MALAWI Technical Briefing for Consultants in Procurement and Supply Management for HIV,
Advertisements

A Call to Action Children – The missing face of AIDS.
Group III: Demand Forecasting
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Harmonization of donor reporting requirements for antiretrovirals and related drugs Presented at the WHO meeting, Geneva ( October 2005) Oteba Olowo.
National PSM Coordination Mechanism Dr Vincent Habiyambere WHO/HIV Department AIDS Medicines & Diagnostics Service (AMDS) Bangkok, July 2005.
AMDS Contribution to the Technical Briefing Seminar October 2007.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Priority Issues and Strategic Information Needs for Kenya in scaling up ART.
The Roadmap to Successful Xpert Implementation - 37 steps -
M.B.A. II SEMESTER Course No. 208 Paper No. – XVI E-Business Dr.N.C.Dhande Objectives Provide analytical and technical framework to understand the emerging.
Scaling up ART in Sénégal: specifics needs for strategic information Mame Awa Toure MD, MSc AIDS/STI Division, MOH Senegal.
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Unit 6 Diagnosis & Follow-up of HIV Infection
Dr Susan Zimba –Tembo Professional Officer – WHO 1 st March 2013, Crest Golf Hotel.
Sound policy and plan formulation. 2 Policy and planning Key messages Policy process is messy, but there are elements of good practice you can use. 1.Sound.
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
Update to IPC on MODEL QUALITY ASSURANCE SYSTEM FOR PROCUREMENT AGENCIES (MQAS) Dr Sabine Kopp 16 December 2014 Update to IPC on MODEL QUALITY ASSURANCE.
UN Prequalification: UNICEF Perspective 5 th UN Prequalification stakeholders meeting 11th February 2009.
Global Fund – PEPFAR Coordination The Tanzania Example Dr. Fatma Mrisho Chairperson TACAIDS.
Global Strategy, Policy and Normative Guidance for POC Diagnostics Gottfried Hirnschall MD, MPH Department of HIV/AIDS, World Health Organization July.
SUPPLY AND PROCUREMENT CHALLENGES: ASSISTIVE PRODUCTS IN EMERGENCIES AND LOW-RESOURCE SETTINGS Shauna Mullally, Technical Specialist for Medical Devices.
Procurement and Supply Management in Moldova Laurentiu IONESII.
Francis Muma, BSc.N, MPH. Fellow, University of Nairobi Institute of Tropical and Infectious Diseases (UNITID). HIV Programme Management and Policy Track.
PROCUREMENT SUPPORT SERVICE WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November 1 st -5 th 2010 Mariatou Tala Jallow, Manager,
National Framework for GFATM Round 7 proposal Dr Rajendra Pant MBBS,MCPS,MPH Deputy Director National Center for AIDS and STD Control Kathmandu Nepal.
Group Discussion Guyana, The Bahamas T & T, Jamaica Barbados, Haiti Suriname, Curacao.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
PROGRAM UPDATE OVERCOMING HIV/AIDS EPIDEMICS IN UKRAINE NATIONAL PROGRAM SUPPORTED BY GFATM COMPONENT: TREATMENT, CARE AND SUPPORT Presentation by Treatment,
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
HIV/AIDS Interface Technology Systems (HITS): A Program Update SPNS IT Grantees Meeting March 17, 2004 County of Los Angeles Department of Health Services.
Lucile de Comarmond Chief Pharmacist Workshop on Impact of TRIPS/IP on Access to Medicine September 2014.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.
1 IASC Weekly meeting Geneva, 14 September 2005 Malaria control in emergency settings Charles Delacollette WHO/Roll Back Malaria Department.
Overcoming HIV/AIDS Epidemic in Ukraine National programme supported by GFATM Presentation by Alvaro Bermejo and Andriy Klepikov at the Stakeholders Meeting.
Child-Responsive Budgeting: budget as an instrument for the realization of child rights Open Forum “The impact of the crisis on children in the south”
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
SPHUNGA HEALTHLINK “WORKER INTERVENTION PROGRAMME” 1.
Overcoming HIV/AIDS Epidemic in Ukraine National programme supported by GFATM.
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics J. Perriëns.
World Health Organization "3 by 5" Target Treat 3 million by 2005.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
Critical PSM bottlenecks and solutions Ukraine Olena Wagner International HIV/AIDS Alliance in Ukraine Procurement and Supply Management Workshop
Scaling-up HIV Prevention, Care and Antiretroviral Therapy at Primary Health Centers A WHO/PEPFAR Collaboration.
Mobilizing Resources for Financial Sustainability Capacity Strengthening Session II Eliana Monteforte, MPH Judith B. Seltzer, MPH, MBA.
E u r o p e a n C o m m i s s i o nCommunity Research Global Change and Ecosystems Malta, 27 January 2004 Alan Edwards EUROPEAN COMMISSION GMES – Implications.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
World Vision Experiences in Making ART Treatment Affordable and Available Dr. Daniel J Malleboyina M.B.B.S, MBA, MPH Regional Advisor HIV & AIDS- Asia.
Province of the Eastern Cape Department of Health Select Committee on Finance 4th Quarter Spending on Conditional Grants and CAPEX 11 th May 07.
Inter-American Development Bank BIMILACI 2007 QUALITY PROCUREMENT Third Party Review May 2007 Project Procurement Division.
HHS/CDC Track 1.0 Transition in Rwanda Dr Ida Kankindi, Rwanda Ministry of Health Dr Felix Kayigamba, CDC-Rwanda August
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
1 The new financial modalities LAF seminar June 2009.
1 Predictors of Immunological Failure Among Adult Patients Receiving ART at an urban, HIV Clinic in Uganda Dr. Muhumuza Simon (M.D, MPH) Mulago-Mbarara.
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Access to Essential Medicines and Supplies
TB/HIV surveillance : Who is going to get the job done?
بنــام خــدا.
Thokozani Kalua MBBS MSc Malawi Ministry of Health
مدیریت امور آزمایشگاهها دانشگاه علوم پزشکی کاشان
المبادئ الأساسية للصحة المهنية
Essential Drugs and Medicines Policy (EDM) World Health Organization
Consolidated Technical Support Plan for AIDS
WHO Global HIV/AIDS Staff Meeting
Dr. Kenneth L. Chebet Director NASCOP/NLTP Division Kenya
HIV /Tuberculosis in the community
Case Brief Yorgos Marinakis
Presentation transcript:

UNICEF SUPPLY DIVISION MEDICAL TECHNICAL TEAM HIV/AIDS: Where Are The Diagnostics ? Ludo Scheerlinck MSc, MBA, MPH

1.Rationale 2.Planning 3.Procurement 4.Yemen/MoH/NAP & GFATM financed HIV/AIDS project Planning & procurement of diagnostics in support of HIV/AIDS programmes

(i)Widely recognised that availability & affordability of Dx modalities hamper fight against HIV/AIDS. (ii)Price trend, seen with ARVs, so far not with Dx. (iii)Dx will continue to consume large part of our available funds. Esp. for lab-based Tx monitoring. Rationale

(iv)Too often assumed Dx will follow automatically when the ARVs are in place; overlooking that: - Status depends on Dx. - Tx initiation depends on Dx. - Tx monitoring depends on Dx. - Installing Dx is technically as complex as ARVs. - Limited capacity/capabilities with sophisticated Dx. (v)Hence importance of professional planning of Dx at the earliest phases of programs/projects possible. (vi)Share weaknesses most often observed, same time request to address them in your consultancy endeavors. Rationale, ctnd

1.Rationale 2.Planning 3.Procurement 4.Yemen/MoH/NAP & GFATM financed HIV/AIDS project Planning & procurement of diagnostics in support of HIV/AIDS programmes

Diagnostics, what are we talking about ?

Planning (1) Adults: (i) Office based (i.e.VCT): Simple/Rapid test (ii) Laboratory, Confirmatory test: ELISA Tx initiation and monitoring: CD4, VL-PCR (Q N ) (iii) Blood bank:ELISA

Planning (2) Children (<18m, early diagnosis): (i)Test kits: No (mat. antibodies) (ii)Laboratory, Testing: VL-PCR (Q L ) Tx initiation and monitoring: CD4%, VL-PCR (Q N )

Planning (3) (i) Allocation should be carefully done based on geography and prevalence/incidence. (ii) Allocation to appropriate service providers: - CD4 from district level providers up. - VL only central level: ! consequences for children. (iii) Caution with perception automatic. Staff skills incl. device, procedures and technical aspects !

Planning (4) (iv) Draft generic specification include: test parameters, throughput, type and number of test per year. (v) Physical environment: - Dedicated lab rooms with s pecific requirements (sample contamination, safety, waste process, etc). - Supporting devices present & functioning.

Planning (5) (vi) In-country logistics: - Shelf-life of some reagents fairly short (ca. 45 days). - Most of them need refrigerated transport & storage. (vii)After sales service: focus on technical representation. (viii) Last, check Dx services the private sector delivers.

Planning (6) (viii) Investment and recurrent cost indication, USD: - Rapid/Simple test: 0.5 to ± ELISA device: reagents: ±1.0 per test - CD4 device: reagents: ± 7.0 per test - VL device: reagents: ± 30 per test P.S. To be added: – reruns – shelf life opened reagents – supporting devices – staff cost – admin and logistics of samples and test results.

Planning (7) Only when at least the above is identified, agreed, described and budgeted: I have properly planned sustainable diagnostics support. Procurement exercise without (too many) surprises can start.

Planning (8) Plenty info available about Dx from numerous of sources. No standard for assessing needs and subsequent planning. Approach case-by-case according country, goals and objectives, stakeholders involved, available budget and so on.

1.Rationale 2.Planning 3.Procurement 4.Yemen/MoH/NAP & GFATM financed HIV/AIDS project Planning & procurement of diagnostics in support of HIV/AIDS programmes

Procurement (1) Rapid/Simple Test: WHO specified & prequalified and tendered. List available online SD website. Analyzers: WHO prices and sources guidelines. If not standardized, public tendered. Generic specs submitted or developed in-house.

Procurement (2) We refuse to just procure & ship-out any BoQ submitted, when reveals inconsistencies vis-à-vis: needs addressed, completeness, or project goals and objectives. Able to add: (i) start-up reagents, (ii) training needs (user, technical, GLP), (iii) specifications supporting devices, (iv) maintenance contract. With post-planning efforts increase risk of deviating from actual needs to be covered on site.

To assist, to a certain extend, with planning and procurement SD develops a short planning brief, informing about: - Dx services to be provide at different levels. - Allocation of technology. - Supporting devices. - Sources to procure from. - Generic specifications (ELISA, CD4 and VL) Procurement (3)

1.Rationale 2.Planning 3.Procurement 4.Yemen/MoH/NAP & GFATM financed HIV/AIDS project Planning & procurement of diagnostics in support of HIV/AIDS programmes

Background Request for CE prior to procurement equipment & supplies for (i) blood bank, and (ii) Tx initiation and monitoring. Different lists were inconsistent, poorly specified and budget indication way of the mark. Grant Agreement, Project Proposal or PSM from GFATM website provided necessary info neither. Three months of communication, no progress. UNICEF/CO/Yemen invited technical support from SD to clarify the matter. 1./ 2./ 3./ 4./

Desk research covering among others: (i)Prevalence, incidence, geographical distribution and other determinants of the epidemic. (ii)Socio-economics of the country. (iii)Health services delivery. (iv)Public-private mix. (v)Health expenditure (pub and private). Mission specific questionnaire as guideline for mission workshops. Proposal for adjustments to BoQ & Specifications. 1./ 2./ 3./ Mission preparation

With MoH/NAP weak link identified between: (i)Prevalence/distribution HIV/AIDS, and (ii)Items requested in support - introduction Tx initiation and monitoring, and - strengthening screening services of blood banks. Upon brief assessment of the situation the MoH/NAP recognised need to re-plan ALL commodities for both projects components. 1./ 2./ 5 days mission (1)

Re-planning exercise covered: Prevalence and geographic distribution of HIV/AIDS: (i)Allowing calculation present and future national capacity for screening donated blood & testing/treatment monitoring. (ii)Allowing allocating devices to service providers involved. Consulting national Tx initiation and monitoring guidelines, i.e. frequency of testing, as this also guides the required capacity of the devices. 1./ 2./ 5 days mission (2)

Site visits hospitals & blood banks, focussing on: (i) present capacity and utilisation, (ii) physical environment (incl. pre-installation requirements, supporting devices). Training needs: (i) user, (ii) technical, (iii) procedures (GLP: emphasising sample collection, transportation, storage and preparation). 3./ 4./ 5 days mission (3)

A new final equipment list; items, specifications and their respective quantity. For budgeting and feasibility appraisal purposes (only) lump sum prices were produced (budget review USD to ). A time line/activities for issuance of cost estimate and subsequent procurement. 1./ 2./ 3./ 5 days mission (4), outcome

Conclusion and lessons learned (1) Context information about a project is essential. Capacity for basic planning (BoQ & Specs) of commodities in a project context limited with UNICEF/CO, MoH and Global Fund. Advanced planning issues s.a. (i) recurrent cost (= sustainability), (ii) training & installation, (iii) physical environment, (iv) in-country logistics (v) waste management unheard of. 1./ 2./ 3./

Technical expertise should have been involved much earlier. Time waste trying to solve complex issues remotely. Project accumulated 5 months delay, seriously jeopardising Year 1 objectives (ARVs also delayed). Quality planning of diagnostics is vital for smooth PSM, but also for a successful sustainable project &program. 4./ 5./ Conclusion and lessons learned (2)

1.Rationale 2.Planning 3.Procurement 4.Yemen/MoH/NAP & GFATM financed HIV/AIDS project Planning & procurement of diagnostics in support of HIV/AIDS programmes

FOR YOUR ATTENTION ! THANK YOU …